Sophie C. Kunte

Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T

N. Albert, C. Stief, P. Bartenstein, 2022, Biomedicines.

PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches

M. Brendel, M. Unterrainer, Vinh Ngoc Bui, 2023, Biomedicines.

Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE

K. Jurkschat, C. Belka, C. Cyran, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice

P. Nelson, C. Walz, J. Marschner, 2023, Frontiers in immunology.

[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis

C. Cyran, F. Gildehaus, M. Unterrainer, 2024, European journal of nuclear medicine and molecular imaging.

Divergent Findings in the Diagnosis of ATTR-CM Using Common Cardiac Diagnostics and 99mTc-DPD Scintigraphy.

M. Unterrainer, A. Holzgreve, L. Unterrainer, 2023, Clinical nuclear medicine.